La FDA aprueba la primera pastilla para tratar la enfermedad de Crohn de moderada a grave
VIERNES, 19 de mayo de 2023 (HealthDay News) — Los pacientes con enfermedad de Crohn cuentan ahora con una nueva opción de tratamiento, después de que la Administración de Alimentos y Medicamentos (FDA) de EE. UU. aprobara una pastilla llamada Rinvoq…
Learn MoreLas citas para pruebas de detección y salud preventiva para la mujer que usted necesita
VIERNES, 19 de mayo de 2023 (HealthDay News) — Las citas para pruebas de detección y atención preventiva son clave para mantener la salud y el bienestar a largo plazo. Al implicarse de forma proactiva en estas prácticas, las mujeres pueden identifica…
Learn MoreLosing Weight Before Atrial Fibrillation Treatment Boosts Outcomes
MONDAY, May 22, 2023 (HealthDay News) — Obese people might be wise to slim down before undergoing an ablation procedure to treat an abnormal heart rhythm, researchers report.Folks with atrial fibrillation who lost 3% or more of their body weight befo…
Learn MorePerceived Access to Firearms Higher in Teens With Depression, Suicidality
MONDAY, May 22, 2023 (HealthDay News) — High school-aged teens with recent depression and/or lifetime history of suicidality (DLHS) have higher perceived access to firearms than their peers without DLHS, according to a study published online May 22 i…
Learn MoreSurgical Treatment Provides Better Long-Term Survival for NSCLC
MONDAY, May 22, 2023 (HealthDay News) — Long-term survival favors surgical management over stereotactic body radiotherapy (SBRT) for treatment of early-stage, non-small cell lung cancer (NSCLC), according to a study presented at the annual meeting of…
Learn MoreLung Transplants From COVID-19-Positive Donors May Be Feasible
MONDAY, May 22, 2023 (HealthDay News) — Carefully selected lung transplants from COVID-19-positive donors have similar early posttransplant outcomes as transplants from COVID-19-negative donors, according to a study presented at the annual meeting of…
Learn MoreEmergency Anaphylaxis Observation Times Can Be Cut for Children
MONDAY, May 22, 2023 (HealthDay News) — Most children seen in the emergency department for anaphylaxis can be discharged after two hours or less, according to a study presented at the annual meeting of the Pediatric Academic Societies, held from Apr…
Learn MorePreop Vascular Interventions Tied to Adverse Outcomes in Lower-Extremity Reconstructions
MONDAY, May 22, 2023 (HealthDay News) — For patients with lower-extremity reconstructions, pre-reconstruction vascular interventions are associated with an increased incidence of adverse outcomes, according to a study published in the April issue of …
Learn MoreWegovy Shows Weight-Loss Effectiveness in Real-World Study
MONDAY, May 22, 2023 (HealthDay News) — It’s a social media darling and one of the hottest prescription medications on the U.S. market. But does Wegovy really help patients lose weight?Yes, a new study suggests.Investigators analyzed data on more tha…
Learn MoreMedicare’s Coverage of Methadone Could Help Get People Off Opioids
MONDAY, May 22, 2023 (HealthDay News) — When Medicare expanded coverage for methadone, more people used this treatment for opioid use disorder, a new study shows.Use rose sharply but did not displace other opioid treatments such as buprenorphine, acc…
Learn More